SNX10 and atherosclerosis: SNX10 controls metabolic reprogramming of macrophages in atherosclerosis by enhancing lysosomal biogenesis and lysosomal acid lipase, thus increasing free fatty acids to fuel mitochondrial fatty acid oxidation (57, 58).